Development of therapeutic agents for older patients with acute myelogenous leukemia.

Item

http://www.wikidata.org/entity/Q36424315

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Development of therapeutic agents for older patients with acute myelogenous leukemia.

@ast

Development of therapeutic agents for older patients with acute myelogenous leukemia.

@en

type

Item

label

Development of therapeutic agents for older patients with acute myelogenous leukemia.

@ast

Development of therapeutic agents for older patients with acute myelogenous leukemia.

@en

prefLabel

Development of therapeutic agents for older patients with acute myelogenous leukemia.

@ast

Development of therapeutic agents for older patients with acute myelogenous leukemia.

@en

P1476

Development of therapeutic agents for older patients with acute myelogenous leukemia

@en

P2093

Christopher S Hourigan

http://www.w3.org/2001/XMLSchema#string

Judith E Karp

http://www.w3.org/2001/XMLSchema#string

P2860

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate

How I treat acute promyelocytic leukemia.

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

Preclinical and clinical development of cyclin-dependent kinase modulators.

Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.

Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.

Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

P304

669-677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20496262

http://www.w3.org/2001/XMLSchema#string

P932

4699173

http://www.w3.org/2001/XMLSchema#string